|
|
||||||||




* Division of Molecular Neuroimmunology, Department of Neurology, University of Heidelberg, Heidelberg, Germany; and
Division of Immunogenetics/Tumorimmunology Program, Deutsches Krebsforschungszentrum, Heidelberg, Germany
The suppressive function of regulatory T cells (Treg) is impaired in multiple sclerosis (MS) patients. The mechanism underlying the Treg functional defect is unknown. Treg mature in the thymus and the majority of cells circulating in the periphery rapidly adopt a memory phenotype. Because our own previous findings suggest that the thymic output of T cells is impaired in MS, we hypothesized that an altered Treg generation may contribute to the suppressive deficiency. We therefore determined the role of Treg that enter the circulation as recent thymic emigrants (RTE) and, unlike their CD45RO+ memory counterparts, express CD31 as typical surface marker. We show that the numbers of CD31+-coexpressing CD4+CD25+CD45RA+CD45RO–FOXP3+ Treg (RTE-Treg) within peripheral blood decline with age and are significantly reduced in MS patients. The reduced de novo generation of RTE-Treg is compensated by higher proportions of memory Treg, resulting in a stable cell count of the total Treg population. Depletion of CD31+ cells from Treg diminishes the suppressive capacity of donor but not patient Treg and neutralizes the difference in inhibitory potencies between the two groups. Overall, there was a clear correlation between Treg-mediated suppression and the prevalence of RTE-Treg, indicating that CD31-expressing naive Treg contribute to the functional properties of the entire Treg population. Furthermore, patient-derived Treg, but not healthy Treg, exhibit a contracted TCR V
repertoire. These observations suggest that a shift in the homeostatic composition of Treg subsets related to a reduced thymic-dependent de novo generation of RTE-Treg with a compensatory expansion of memory Treg may contribute to the Treg defect associated with MS.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by the Gemeinnützige Hertie-Stiftung (1.01.1/04/003), Deutsche Forschungsgemeinschaft (Sonderforschungsbereich (SFB) 405, 5H and SFB 571, B7), the Young Investigator Award from the Faculty of Medicine, University of Heidelberg (to B.F.), and Serono Deutschland GmbH.
2 Address correspondence and reprint requests to Dr. Brigitte Wildemann, Division of Molecular Neuroimmunology, Department of Neurology, University of Heidelberg, INF 350, Heidelberg, Germany. E-mail address: brigitte_wildemann{at}med.uni-heidelberg.de
3 Abbreviations used in this paper: Treg, regulatory T cell; CS, complexity score; GA, glatiramer acetate; HC, healthy control; MS, multiple sclerosis; RRMS, relapsing remitting MS; RTE, recent thymic emigrant; Teff, effector T cell; TREC, TCR excision circle.
Related articles in The JI:
This article has been cited by other articles:
![]() |
X. Chen, L. Fang, S. Song, T. B. Guo, A. Liu, and J. Z. Zhang Thymic Regulation of Autoimmune Disease by Accelerated Differentiation of Foxp3+ Regulatory T Cells through IL-7 Signaling Pathway J. Immunol., November 15, 2009; 183(10): 6135 - 6144. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Brahmachari and K. Pahan Suppression of Regulatory T Cells by IL-12p40 Homodimer via Nitric Oxide J. Immunol., August 1, 2009; 183(3): 2045 - 2058. [Abstract] [Full Text] [PDF] |
||||
![]() |
A R Lorenzi, T A Morgan, A Anderson, J Catterall, A M Patterson, H E Foster, and J D Isaacs Thymic function in juvenile idiopathic arthritis Ann Rheum Dis, June 1, 2009; 68(6): 983 - 990. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Oh, G. Blevins, C. Griffith, N. Richert, D. Maric, C. R. Lee, H. McFarland, and S. Jacobson Regulatory T Cells Are Reduced During Anti-CD25 Antibody Treatment of Multiple Sclerosis Arch Neurol, April 1, 2009; 66(4): 471 - 479. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Korporal, J. Haas, B. Balint, B. Fritzsching, A. Schwarz, S. Moeller, B. Fritz, E. Suri-Payer, and B. Wildemann Interferon Beta-Induced Restoration of Regulatory T-Cell Function in Multiple Sclerosis Is Prompted by an Increase in Newly Generated Naive Regulatory T Cells Arch Neurol, November 1, 2008; 65(11): 1434 - 1439. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Saresella, I. Marventano, R. Longhi, F. Lissoni, D. Trabattoni, L. Mendozzi, D. Caputo, and M. Clerici CD4+CD25+FoxP3+PD1- regulatory T cells in acute and stable relapsing-remitting multiple sclerosis and their modulation by therapy FASEB J, October 1, 2008; 22(10): 3500 - 3508. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Venken, N. Hellings, T. Broekmans, K. Hensen, J.-L. Rummens, and P. Stinissen Natural Naive CD4+CD25+CD127low Regulatory T Cell (Treg) Development and Function Are Disturbed in Multiple Sclerosis Patients: Recovery of Memory Treg Homeostasis during Disease Progression J. Immunol., May 1, 2008; 180(9): 6411 - 6420. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |